Person A/Pr Jake Shortt National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A phase I study of the first in class dual IMiD/bromodomain inhibitor N-methyl-2-pyrrolidone (NMP) in relapsed and refractory multiple myeloma. (funded by National Health and Medical Research Council) Participant in Exploiting and defining the immune regulatory activities of BET bromodomain inhibitors (funded by National Health and Medical Research Council) Principal investigator of Molecular & Translational Characterisation of IMiD-Mediated BET-Protein Degradation in Multiple Myeloma (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A phase I study of the first in class dual IMiD/bromodomain inhibitor N-methyl-2-pyrrolidone (NMP) in relapsed and refractory multiple myeloma. (funded by National Health and Medical Research Council) Participant in Exploiting and defining the immune regulatory activities of BET bromodomain inhibitors (funded by National Health and Medical Research Council) Principal investigator of Molecular & Translational Characterisation of IMiD-Mediated BET-Protein Degradation in Multiple Myeloma (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover